News
HQH
19.76
-0.20%
-0.04
Weekly Report: what happened at HQH last week (0406-0410)?
Weekly Report · 3d ago
How To Find Funds That Beat The S&P 500 For Retirement
Seeking Alpha · 04/08 13:30
I Demand Recurrent Income For My Retirement
Seeking Alpha · 04/08 11:35
Weekly Report: what happened at HQH last week (0330-0403)?
Weekly Report · 04/06 09:59
Press Release: Aberdeen Investments U.S. -2-
Dow Jones · 03/31 20:17
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Dow Jones · 03/31 20:17
Weekly Report: what happened at HQH last week (0323-0327)?
Weekly Report · 03/30 10:00
Weekly Report: what happened at HQH last week (0316-0320)?
Weekly Report · 03/23 09:56
5 'Healthy' Dividends Paying Up to 14.1%
NASDAQ · 03/20 13:30
Weekly Report: what happened at HQH last week (0309-0313)?
Weekly Report · 03/16 09:56
Weekly Report: what happened at HQH last week (0302-0306)?
Weekly Report · 03/09 09:57
HQH: Strong Returns Fuel Higher Payout, But Valuation Not As Compelling (Downgrade)
Seeking Alpha · 03/03 22:28
Weekly Report: what happened at HQH last week (0223-0227)?
Weekly Report · 03/02 09:57
Weekly Report: what happened at HQH last week (0216-0220)?
Weekly Report · 02/23 09:57
Be The General Contractor: Build Your Double-Digit-Yielding Portfolio
Seeking Alpha · 02/20 13:30
Abrdn Healthcare Investors Q4 2025 Commentary
Seeking Alpha · 02/20 01:10
Weekly Report: what happened at HQH last week (0209-0213)?
Weekly Report · 02/16 09:56
abrdn Healthcare Investors declares $0.63 dividend
Seeking Alpha · 02/11 07:22
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Dow Jones · 02/10 21:17
Press Release: Certain Aberdeen Investments U.S. -2-
Dow Jones · 02/10 21:17
More
Webull provides a variety of real-time HQH stock news. You can receive the latest news about abrdn Healthcare Investors through multiple platforms. This information may help you make smarter investment decisions.
About HQH
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management. The Fund invests primarily in securities of public and private companies, which have potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of the United States issuers that are traded primarily in foreign markets. The Fund's investment advisor is Tekla Capital Management LLC.